Health
New staging system can inform treatment decisions for non-metastatic prostate cancer – News-Medical.Net
Doctors and biostatisticians at the University of Michigan Rogel Cancer Center have led the development and validation of a staging system to better predict outcomes…
Reviewed by Emily Henderson, B.Sc.Oct 23 2020
Doctors and biostatisticians at the University of Michigan Rogel Cancer Center have led the development and validation of a staging system to better predict outcomes and inform treatment decisions for men diagnosed with non-metastatic prostate cancer.
Although it is one of the most common cancers worldwide, prostate cancer remains one of the few major cancers for which the familiar, numerical staging system -; ranging from stage 1 to stage 4 -; has not…
-
Noosa News23 hours agoCCTV footage shows stolen ute slamming into fuel bowsers at Kojonup petrol station
-
Business23 hours agoWill GQG Partners shares rise from here? Macquarie reveals its forecast post-results
-
Noosa News19 hours agoThe only person detained at Brisbane’s Palestine rally
-
Noosa News24 hours agoPappa Flock is Now Open in Westfield Chermside